Matrix therapy combined with mesenchymal stem cells-based approach in the context of brain ischemia
Charlène Renoult(Imagerie et Stratégies Thérapeutiques pour les Cancers et Tissus cérébraux), Myriam Bernaudin(Centre National de la Recherche Scientifique), Marie-Sophie Quittet(Centre National de la Recherche Scientifique), Dulce Papy-García(Université Paris-Est Créteil), Jérôme Toutain(Centre National de la Recherche Scientifique), Rozenn Le Gal(Cyceron), Denis Barritault(Délégation Paris 7), Yacine Khelif(Centre National de la Recherche Scientifique), Franck Chiappini(Délégation Paris 7), Xavier Laffray(Centre National de la Recherche Scientifique), Omar Touzani(Centre National de la Recherche Scientifique), Carole Brunaud(Imagerie et Stratégies Thérapeutiques pour les Cancers et Tissus cérébraux)
HAL (Le Centre pour la Communication Scientifique Directe)
July 9, 2022
Cited by 0
Related Papers
Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds
|Proceedings of the National Academy of Sciences|2013|864
Heparan Sulfate Is a Cellular Receptor for Purified Infectious Prions
|Journal of Biological Chemistry|2005|175
The 37‐kDa/67‐kDa Laminin Receptor Acts as a Receptor for Infectious Prions and Is Inhibited by Polysulfated Glycanes
|The Journal of Infectious Diseases|2006|126
Repurposing doxycycline for synucleinopathies: remodelling of α-synuclein oligomers towards non-toxic parallel beta-sheet structured species
|Scientific Reports|2017|120
Elastin-like recombinamers-based hydrogel modulates post-ischemic remodeling in a non-transmural myocardial infarction in sheep
|Science Translational Medicine|2021|100